JP2023505255A5 - - Google Patents
Info
- Publication number
- JP2023505255A5 JP2023505255A5 JP2022533510A JP2022533510A JP2023505255A5 JP 2023505255 A5 JP2023505255 A5 JP 2023505255A5 JP 2022533510 A JP2022533510 A JP 2022533510A JP 2022533510 A JP2022533510 A JP 2022533510A JP 2023505255 A5 JP2023505255 A5 JP 2023505255A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ophthalmic pharmaceutical
- months
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025117830A JP2025160247A (ja) | 2019-12-05 | 2025-07-14 | 眼科用医薬組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944074P | 2019-12-05 | 2019-12-05 | |
| US62/944,074 | 2019-12-05 | ||
| US202063077196P | 2020-09-11 | 2020-09-11 | |
| US63/077,196 | 2020-09-11 | ||
| PCT/US2020/063218 WO2021113580A1 (en) | 2019-12-05 | 2020-12-04 | Ophthalmic pharmaceutical compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025117830A Division JP2025160247A (ja) | 2019-12-05 | 2025-07-14 | 眼科用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023505255A JP2023505255A (ja) | 2023-02-08 |
| JP2023505255A5 true JP2023505255A5 (enExample) | 2023-12-05 |
| JP7833399B2 JP7833399B2 (ja) | 2026-03-19 |
Family
ID=74104179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533510A Active JP7833399B2 (ja) | 2019-12-05 | 2020-12-04 | 眼科用医薬組成物 |
| JP2025117830A Withdrawn JP2025160247A (ja) | 2019-12-05 | 2025-07-14 | 眼科用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025117830A Withdrawn JP2025160247A (ja) | 2019-12-05 | 2025-07-14 | 眼科用医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230026577A1 (enExample) |
| EP (1) | EP4069195A1 (enExample) |
| JP (2) | JP7833399B2 (enExample) |
| KR (1) | KR20220128619A (enExample) |
| CN (1) | CN115397392A (enExample) |
| AU (1) | AU2020398224B2 (enExample) |
| BR (1) | BR112022010871A2 (enExample) |
| CA (1) | CA3160484A1 (enExample) |
| CL (1) | CL2022001463A1 (enExample) |
| CO (1) | CO2022009260A2 (enExample) |
| IL (1) | IL293541A (enExample) |
| MX (1) | MX2022006776A (enExample) |
| TW (1) | TWI845795B (enExample) |
| WO (1) | WO2021113580A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300628A (en) | 2020-09-10 | 2023-04-01 | Vanda Pharmaceuticals Inc | Methods for the treatment of cyclic diseases or conditions-PDE IV |
| HU231668B1 (hu) * | 2021-12-28 | 2025-06-28 | Semmelweis Egyetem 60% | Szemcsepp készítmény |
| WO2025054370A1 (en) * | 2023-09-06 | 2025-03-13 | Opus Life Sciences, Llc | High ph formulations and kits |
| WO2025179141A1 (en) | 2024-02-22 | 2025-08-28 | Vanda Pharmaceuticals, Inc. | Treatment of dry eye disease |
| WO2026075334A1 (ko) * | 2024-10-02 | 2026-04-09 | 주식회사 대웅테라퓨틱스 | 개선된 안정성 및 투약 편의성을 갖는 레바미피드를 포함하는 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2422031C (en) | 2000-09-13 | 2011-11-15 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solutions comprising difluoroprostaglandin f2 alpha |
| CN101537172B (zh) | 2008-08-14 | 2010-06-30 | 温州医学院 | 一种含有重组人角质细胞生长因子-2滴眼液及其制备方法 |
| CN101690712B (zh) | 2009-08-25 | 2011-06-15 | 武汉武药科技有限公司 | 一种西他沙星滴眼剂及其制备方法 |
| US20110178147A1 (en) | 2009-10-20 | 2011-07-21 | Allergan, Inc. | Compositions and methods for controlling pupil dilation |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| CN102988280B (zh) | 2012-10-08 | 2014-03-19 | 新乡医学院 | 一种加雷沙星滴眼剂 |
| CN106074568B (zh) * | 2015-09-02 | 2021-05-14 | 盛世泰科生物医药技术(苏州)有限公司 | 一种用于预防和治疗白内障的眼用制剂及其制备方法 |
| WO2017083799A1 (en) * | 2015-11-13 | 2017-05-18 | Ohr Pharmaceutical, Inc. | Ophthalmic formulations of squalamine |
| ES3066112T3 (en) | 2015-12-24 | 2026-05-11 | The Regents Of The Univ Of California | Cftr regulators and methods of use thereof |
| WO2018156593A1 (en) | 2017-02-21 | 2018-08-30 | Avedro, Inc. | Formulations for eye treatments |
| EP3672598A4 (en) | 2017-08-24 | 2021-04-28 | The Regents of The University of California | OCULAR PHARMACEUTICAL COMPOSITIONS |
-
2020
- 2020-12-04 TW TW109142969A patent/TWI845795B/zh active
- 2020-12-04 EP EP20830416.2A patent/EP4069195A1/en active Pending
- 2020-12-04 WO PCT/US2020/063218 patent/WO2021113580A1/en not_active Ceased
- 2020-12-04 KR KR1020227022823A patent/KR20220128619A/ko active Pending
- 2020-12-04 CA CA3160484A patent/CA3160484A1/en active Pending
- 2020-12-04 MX MX2022006776A patent/MX2022006776A/es unknown
- 2020-12-04 IL IL293541A patent/IL293541A/en unknown
- 2020-12-04 BR BR112022010871A patent/BR112022010871A2/pt unknown
- 2020-12-04 JP JP2022533510A patent/JP7833399B2/ja active Active
- 2020-12-04 CN CN202080094414.9A patent/CN115397392A/zh active Pending
- 2020-12-04 US US17/782,197 patent/US20230026577A1/en active Pending
- 2020-12-04 AU AU2020398224A patent/AU2020398224B2/en active Active
-
2022
- 2022-06-02 CL CL2022001463A patent/CL2022001463A1/es unknown
- 2022-07-01 CO CONC2022/0009260A patent/CO2022009260A2/es unknown
-
2025
- 2025-07-14 JP JP2025117830A patent/JP2025160247A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102607126B1 (ko) | 안과용 조성물 | |
| CN100551378C (zh) | 包含氨基糖苷类抗生素和溴芬酸的水溶液制剂 | |
| CO5210868A1 (es) | Composiciones que tienen estabilidad mejorada | |
| BR112014023402B1 (pt) | Solução oftálmica compreendendo diquafosol e métodos para produção da mesma, para inibição da formação dos precipitados insolúveis na mesma, para redução da irritação ocular causada pela mesma e para aumentar a eficácia de conservação da mesma | |
| AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
| JP2017514924A5 (enExample) | ||
| JP2022511335A5 (enExample) | ||
| CN102014618A (zh) | 微乳剂型杀菌组合物 | |
| JP2024040421A5 (enExample) | ||
| CA2535533A1 (en) | Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline | |
| CN108184891A (zh) | 一种杀菌剂乳液及其制备方法 | |
| CN103608000B (zh) | 含有透明质酸或其盐以及丙二醇的滴眼液 | |
| CN103348967B (zh) | 一种用于家禽人工授精的精液稀释液及其使用方法 | |
| JP2011105706A (ja) | 眼科用剤 | |
| KR102489633B1 (ko) | 점안 조성물 | |
| JP5922609B2 (ja) | ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性組成物 | |
| JP4754149B2 (ja) | 水性液剤 | |
| CN115137699B (zh) | 一种增效防腐的右美托咪定鼻喷剂 | |
| JP4132807B2 (ja) | ヨウ素系濃縮防殺菌剤組成物 | |
| CN104106566B (zh) | 一种邻苯二甲醛消毒剂及其制备方法 | |
| CN102215819B (zh) | 具有相对低的离子强度的药物组合物 | |
| CN104430552A (zh) | 一种池塘杀菌药物配方 | |
| US2132351A (en) | Stable aqueous solutions of subtances having an anesthetic effect | |
| CN117838628B (zh) | 一种地夸磷索钠滴眼液及其制备方法 | |
| WO2015046281A1 (ja) | 安定化された２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物 |